您的购物车当前为空
AK-HW-90 (compound 2B) 是一种有效的泛Bcr-Abl抑制剂,对Imatinib耐药突变体展现出显著的抑制活性。其对耐药突变体Bcr-AblT315I的IC50为0.65 nM。AK-HW-90 具有潜在的抗癌活性,可应用于慢性粒细胞白血病 (CML) 的研究。
AK-HW-90 (compound 2B) 是一种有效的泛Bcr-Abl抑制剂,对Imatinib耐药突变体展现出显著的抑制活性。其对耐药突变体Bcr-AblT315I的IC50为0.65 nM。AK-HW-90 具有潜在的抗癌活性,可应用于慢性粒细胞白血病 (CML) 的研究。

AK-HW-90 相关产品
| 产品描述 | AK-HW-90 (compound 2B) is a potent pan-Bcr-Abl inhibitor that shows significant inhibitory activity against Imatinib-resistant mutants. It inhibits the resistant Bcr-AblT315I mutant with an IC50 of 0.65 nM. AK-HW-90 offers potential anti-cancer properties and can be utilized in chronic myeloid leukemia (CML) research. |
| 分子式 | C27H29N5O2S |
| 存储 | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
评论内容